Document ID: chunk:federal_register_of_legislation:F2018L01175:reg:9:p3
Version: federal_register_of_legislation:F2018L01175
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 9128–10676

cocaine, lidocaine, methylphenidate and narcotics.

            Note 2: Examples of irritant substances include gases (ammonia, chlorine, mustard, nitrogen dioxide, sulphur dioxide), powdered solids (aspirin, baking soda, levamisole, capsules, tablets, pills) and lewisite.

            Note 3: Examples of acute nasal symptoms or signs include rhinorrhoea, and the inflammation, oedema, ulceration or haemorrhage of the nasal mucosa.
(19)      inhaling airborne dusts, smoke from fires, or fumes or vapours from fuel or a chemical agent within the 48 hours before the clinical worsening of sinusitis;
(20)      for sinusitis affecting the maxillary sinus only, having a specified dental condition affecting the tissues adjacent to the affected maxillary sinus at the time of the clinical worsening of sinusitis;
Note: specified dental condition is defined in the Schedule 1 - Dictionary.
(21)      for sinusitis with nasal polyps only, using a drug belonging to the nonselective (COX-1 and COX-2 inhibitors) nonsteroidal anti-inflammatory class of drugs, at the time of the clinical worsening of sinusitis;
            Note: Nonselective (COX-1 and COX-2 inhibitors) nonsteroidal anti-inflammatory class of drugs:
              (a) includes drugs such as aspirin, diclofenac, ibuprofen, indomethacin, ketoprofen, ketorolac, mefanamic acid, paracetamol, piroxicam and sulindac; and

              (b) excludes drugs such as celecoxib, etoricoxib, meloxicam and parecoxib.
(22)      inability to obtain appropriate clinical management for sinusitis.